Toxicity, health-related quality of life and sexuality after molecular profile-based adjuvant treatment in high-intermediate risk endometrial cancer, PORTEC-4a
Anne Sophie V. M. Van den Heerik, Cathalijne C. B. Post, Marie A. D. Haverkort, Nienke Kuijsters, Stefan Kommoss, Friederike L. A. Koppe, Marlies E. Nowee, Henrike Westerveld, Maria A. A. De Jong, Filip Frühauf, Jeltsje S. Cnossen, Jan Willem M. Mens, Jannet C. Beukema, Cyrus Chargari, Charles Gillham, Dorine S. J. Tseng, Katrien Vandecasteele, Karen Verhoeven-Adema, Hans W. Nijman, Remi A. Nout, Bastiaan G. Wortman, Stephanie M. De Boer, Hein Putter, Vincent T. H. B. M Smit, Carien L. Creutzber British Journal of Cancer
· Springer Nature
· 2026-11-11
· DOI: 10.1038/s41416-026-03642-4
Abstract
British Journal of Cancer, Published online: 11 November 2026; doi:10.1038/s41416-026-03642-4 Toxicity, health-related quality of life and sexuality after molecular profile-based adjuvant treatment in high-intermediate risk endometrial cancer, PORTEC-4a
Anne Sophie V. M. Van den Heerik, Cathalijne C. B. Post, Marie A. D. Haverkort, Nienke Kuijsters, Stefan Kommoss, Friederike L. A. Koppe et al. Toxicity, health-related quality of life and sexuality after molecular profile-based adjuvant treatment in high-intermediate risk endometrial cancer, PORTEC-4a. // British Journal of Cancer. – 2026. – DOI: 10.1038/s41416-026-03642-4. – URL: https://www.nature.com/articles/s41416-026-03642-4
Anne Sophie V. M. Van den Heerik, Cathalijne C. B. Post, Marie A. D. Haverkort, Nienke Kuijsters, Stefan Kommoss, Friederike L. A. Koppe, Marlies E. Nowee, Henrike Westerveld, Maria A. A. De Jong, Filip Frühauf, Jeltsje S. Cnossen, Jan Willem M. Mens, Jannet C. Beukema, Cyrus Chargari, Charles Gillham, Dorine S. J. Tseng, Katrien Vandecasteele, Karen Verhoeven-Adema, Hans W. Nijman, Remi A. Nout, Bastiaan G. Wortman, Stephanie M. De Boer, Hein Putter, Vincent T. H. B. M Smit, & Carien L. Creutzber (2026). Toxicity, health-related quality of life and sexuality after molecular profile-based adjuvant treatment in high-intermediate risk endometrial cancer, PORTEC-4a. British Journal of Cancer. https://doi.org/10.1038/s41416-026-03642-4
Anne Sophie V. M. Van den Heerik, et al. “Toxicity, health-related quality of life and sexuality after molecular profile-based adjuvant treatment in high-intermediate risk endometrial cancer, PORTEC-4a.” British Journal of Cancer, 2026. doi:10.1038/s41416-026-03642-4.
@article{Heerik2026,
title = {Toxicity, health-related quality of life and sexuality after molecular profile-based adjuvant treatment in high-intermediate risk endometrial cancer, PORTEC-4a},
author = {Heerik, Anne Sophie V. M. Van den and Post, Cathalijne C. B. and Haverkort, Marie A. D. and Kuijsters, Nienke and Kommoss, Stefan and Koppe, Friederike L. A. and Nowee, Marlies E. and Westerveld, Henrike and Jong, Maria A. A. De and Frühauf, Filip and Cnossen, Jeltsje S. and Mens, Jan Willem M. and Beukema, Jannet C. and Chargari, Cyrus and Gillham, Charles and Tseng, Dorine S. J. and Vandecasteele, Katrien and Verhoeven-Adema, Karen and Nijman, Hans W. and Nout, Remi A. and Wortman, Bastiaan G. and Boer, Stephanie M. De and Putter, Hein and Smit, Vincent T. H. B. M and Creutzber, Carien L.},
journal = {British Journal of Cancer},
year = {2026},
doi = {10.1038/s41416-026-03642-4},
url = {https://www.nature.com/articles/s41416-026-03642-4}
}
Nature Reviews Cancer, Published online: 19 November 2026; doi:10.1038/s41568-026-01001-2 In this Journal Club, Chien-Han Kao and Ruey-Hwa Chen discuss a study showing that tumours use both de novo purine biosynthesis and purine salvage...
npj Precision Oncology, Published online: 19 November 2026; doi:10.1038/s41698-026-01779-2 Targeting SMYD3 in cancer-associated fibroblasts relieves immune suppression and improves anti-PD-L1 response in HPV-negative HNSCC
npj Precision Oncology, Published online: 19 November 2026; doi:10.1038/s41698-026-01786-3 Postoperative timing effects on AI-based resection-cavity segmentation in glioma: multi-site evaluation and relevance assessment